Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2018 Filed Apr 3, 2018 19:11 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 253.199 | $0.00 Strike: $108.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000107 · edgar.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,279.314 Underlying: Common Stock · 253.199 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 38.987 phantom stock units accrued on January 29, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 19:08 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 253.199 | $0.00 Strike: $108.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000103 · edgar.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,253.671 Underlying: Common Stock · 253.199 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 16.446 phantom stock units accrued on January 29, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 19:10 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 218.672 | $0.00 Strike: $108.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000105 · edgar.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500.647 Underlying: Common Stock · 218.672 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 109.336 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 109.336 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 7.659 phantom stock units accrued on January 29, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 19:09 UTC |
BOUDREAUX GAILDirector
|
GrantPhantom Stock Units · Derivative | 218.672 | $0.00 Strike: $108.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000104 · edgar.xml · derivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,596.248 Underlying: Common Stock · 218.672 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 13.462 phantom stock units accrued on January 29, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 19:07 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 218.672 | $0.00 Strike: $108.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000102 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,027.922 Underlying: Common Stock · 218.672 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 14.271 phantom stock units accrued on January 29, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:13 UTC |
Yi SangPresident, Asia Pacific
|
GrantEmployee Stock Option (right to buy) · Derivative | 24,075 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000073 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,075 Underlying: Common Stock · 24,075 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:13 UTC |
Williamson Daniel E.Group President
|
GrantEmployee Stock Option (right to buy) · Derivative | 18,520 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000072 · edgar.xml · derivative · entry 1 Williamson Daniel E. · CIK 0001602430 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,520 Underlying: Common Stock · 18,520 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:12 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,235 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000071 · edgar.xml · derivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,235 Underlying: Common Stock · 22,235 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:12 UTC |
Nolan David A. Jr.Group President
|
GrantEmployee Stock Option (right to buy) · Derivative | 18,520 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000070 · edgar.xml · derivative · entry 1 Nolan David A. Jr. · CIK 0001635757 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,520 Underlying: Common Stock · 18,520 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:11 UTC |
Mazur-Hofsaess KatarzynaPres., Eur., M. East & Afr.
|
GrantEmployee Stock Option (right to buy) · Derivative | 27,780 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000069 · edgar.xml · derivative · entry 1 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,780 Underlying: Common Stock · 27,780 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:11 UTC |
Hanson Bryan CDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 131,485 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000068 · edgar.xml · derivative · entry 1 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,485 Underlying: Common Stock · 131,485 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:10 UTC |
Delp Robert D.President, Americas
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,375 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000066 · edgar.xml · derivative · entry 1 Delp Robert D. · CIK 0001696948 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,375 Underlying: Common Stock · 20,375 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:10 UTC |
Florin Daniel PSr. VP, CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 42,595 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000067 · edgar.xml · derivative · entry 1 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,595 Underlying: Common Stock · 42,595 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:08 UTC |
Collins Tony W.VP, Controller and CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,335 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000065 · edgar.xml · derivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,335 Underlying: Common Stock · 8,335 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:07 UTC |
Bruneau AureGroup President
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,120 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000064 · edgar.xml · derivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,120 Underlying: Common Stock · 11,120 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| March 20, 2018 Filed Aug 29, 2023 22:51 UTC |
BERNARD BETSY JDirector
|
PurchaseCommon Stock | 150 | $111.89 | $16,783.01 |
DisclosureSEC source: 0001062993-23-017221 · form4.xml · nonDerivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150 F1 · price: Reflects the weighted average price of 150 shares of common stock purchased in two transactions on March 20, 2018, with 50 shares purchased at $111.90 and 100 shares purchased at $111.18. Read SEC document |
| February 20, 2018 Filed Feb 20, 2018 21:37 UTC |
Hanson Bryan CDirector · President and CEO
|
PurchaseCommon Stock | 15 | $119.86 | $1,797.89 |
DisclosureSEC source: 0000911916-18-000029 · edgar.xml · nonDerivative · entry 4 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,077 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:38 UTC |
Yi SangPresident, Asia Pacific
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,565 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000047 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,565 Underlying: Common Stock · 21,565 shares Expires 2028-02-20 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:38 UTC |
Williamson Daniel E.Group President
|
GrantEmployee Stock Option (right to buy) · Derivative | 19,605 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000046 · edgar.xml · derivative · entry 1 Williamson Daniel E. · CIK 0001602430 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,605 Underlying: Common Stock · 19,605 shares Expires 2028-02-20 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:37 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 25,485 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000045 · edgar.xml · derivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,485 Underlying: Common Stock · 25,485 shares Expires 2028-02-20 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:37 UTC |
Nolan David A. Jr.Group President
|
GrantEmployee Stock Option (right to buy) · Derivative | 19,605 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000044 · edgar.xml · derivative · entry 1 Nolan David A. Jr. · CIK 0001635757 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,605 Underlying: Common Stock · 19,605 shares Expires 2028-02-20 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:36 UTC |
Mazur-Hofsaess KatarzynaPres., Eur., M. East & Afr.
|
GrantEmployee Stock Option (right to buy) · Derivative | 33,325 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000043 · edgar.xml · derivative · entry 1 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,325 Underlying: Common Stock · 33,325 shares Expires 2028-02-20 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:36 UTC |
Florin Daniel PSr. VP, CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 45,085 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000042 · edgar.xml · derivative · entry 1 Florin Daniel P · CIK 0001402459 · Sr. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,085 Underlying: Common Stock · 45,085 shares Expires 2028-02-20 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:35 UTC |
Delp Robert D.President, Americas
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,565 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000041 · edgar.xml · derivative · entry 1 Delp Robert D. · CIK 0001696948 · President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,565 Underlying: Common Stock · 21,565 shares Expires 2028-02-20 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:35 UTC |
Collins Tony W.VP, Controller and CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,785 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000040 · edgar.xml · derivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,785 Underlying: Common Stock · 10,785 shares Expires 2028-02-20 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:34 UTC |
Bruneau AureGroup President
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,765 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000039 · edgar.xml · derivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,765 Underlying: Common Stock · 11,765 shares Expires 2028-02-20 Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:37 UTC |
Hanson Bryan CDirector · President and CEO
|
PurchaseCommon Stock | 545 | $119.38 | $65,060.63 |
DisclosureSEC source: 0000911916-18-000029 · edgar.xml · nonDerivative · entry 3 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,062 Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:37 UTC |
Hanson Bryan CDirector · President and CEO
|
PurchaseCommon Stock | 11,915 | $119.78 | $1,427,138.19 |
DisclosureSEC source: 0000911916-18-000029 · edgar.xml · nonDerivative · entry 2 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,517 F2 · price: Represents the purchase of 11,915 shares in multiple transactions, ranging in price from $119.715 to $119.895 per share, resulting in a weighted average purchase price of $119.7766. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:37 UTC |
Hanson Bryan CDirector · President and CEO
|
PurchaseCommon Stock | 12,602 | $119.60 | $1,507,213.06 |
DisclosureSEC source: 0000911916-18-000029 · edgar.xml · nonDerivative · entry 1 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,602 F1 · price: Represents the purchase of 12,602 shares in multiple transactions, ranging in price from $118.72 to $119.71 per share, resulting in a weighted average purchase price of $119.6011. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 14:35 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 27,000 | $0.00 Strike: $78.53 | $0.00 |
DisclosureSEC source: 0000911916-18-000026 · edgar.xml · derivative · entry 4 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,000 shares Expires 2018-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Vested annually over four years in increments of 25% each year, commencing on February 12, 2009. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 14:35 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
SaleCommon Stock | 8,372 | $116.41 | $974,617.17 |
DisclosureSEC source: 0000911916-18-000026 · edgar.xml · nonDerivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,017 F3 · price: Represents the sale of 8,372 shares in multiple transactions, ranging in price from $116.05 to $116.78 per share, resulting in a weighted average sale price of $116.4139. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 14:35 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
SaleCommon Stock | 12,454 | $115.64 | $1,440,136.97 |
DisclosureSEC source: 0000911916-18-000026 · edgar.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,389 F2 · price: Represents the sale of 12,454 shares in multiple transactions, ranging in price from $115.05 to $116.04 per share, resulting in a weighted average sale price of $115.6365. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 14:35 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionCommon Stock | 27,000 | $78.53 | $2,120,310.00 |
DisclosureSEC source: 0000911916-18-000026 · edgar.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 148 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between June 30, 2017 and January 30, 2018 and 198 shares purchased between July 28, 2017 and January 29, 2018 under the dividend reinvestment plan for the Company's common stock. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 14:02 UTC |
GLASSCOCK LARRY CDirector
|
Exercise / conversionNon-Employee Director Stock Option (right to buy) · Derivative | 485 | $0.00 Strike: $72.59 | $0.00 |
DisclosureSEC source: 0000911916-18-000023 · edgar.xml · derivative · entry 3 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 485 shares Expires 2018-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 14:02 UTC |
GLASSCOCK LARRY CDirector
|
Exercise / conversionCommon Stock | 485 | $72.59 | $35,206.15 |
DisclosureSEC source: 0000911916-18-000023 · edgar.xml · nonDerivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 59 shares purchased under the dividend reinvestment plan for Zimmer Biomet Holdings, Inc.'s common stock. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:09 UTC |
Bruneau AureGroup President
|
Exercise / conversionRestricted Stock Units · Derivative | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000020 · edgar.xml · derivative · entry 3 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555 Underlying: Common Stock · 185 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: The 740 RSUs in this grant vest annually over four years in increments of 25% each year, commencing January 3, 2018. F3 · derivative.expiration_date: The 740 RSUs in this grant vest annually over four years in increments of 25% each year, commencing January 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:09 UTC |
Bruneau AureGroup President
|
Tax withholdingCommon Stock | 61 | $124.68 | $7,605.18 |
DisclosureSEC source: 0000911916-18-000020 · edgar.xml · nonDerivative · entry 2 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124 F1 · shares: Represents shares withled by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:09 UTC |
Bruneau AureGroup President
|
Exercise / conversionCommon Stock | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000020 · edgar.xml · nonDerivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 18:32 UTC |
Rhodes Jeffrey K.Director
|
GrantPhantom Stock Units · Derivative | 97.906 | $0.00 Strike: $121.29 | $0.00 |
DisclosureSEC source: 0000911916-18-000018 · edgar.xml · derivative · entry 1 Rhodes Jeffrey K. · CIK 0001560940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,176.934 Underlying: Common Stock · 97.906 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 4.053 phantom stock units accrued on October 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 18:31 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 195.812 | $0.00 Strike: $121.29 | $0.00 |
DisclosureSEC source: 0000911916-18-000017 · edgar.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,346.217 Underlying: Common Stock · 195.812 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 97.906 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 97.906 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 6.141 phantom stock units accrued on October 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 18:30 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 226.73 | $0.00 Strike: $121.29 | $0.00 |
DisclosureSEC source: 0000911916-18-000016 · edgar.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,987.128 Underlying: Common Stock · 226.73 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 40.469 phantom stock units accrued on October 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 18:30 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 237.036 | $0.00 Strike: $121.29 | $0.00 |
DisclosureSEC source: 0000911916-18-000015 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,367.723 Underlying: Common Stock · 237.036 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 31.444 phantom stock units accrued on October 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 18:29 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 195.812 | $0.00 Strike: $121.29 | $0.00 |
DisclosureSEC source: 0000911916-18-000014 · edgar.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,274.316 Underlying: Common Stock · 195.812 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 97.906 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 97.906 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 7.950 phantom stock units accrued on October 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 18:28 UTC |
BOUDREAUX GAILDirector
|
GrantPhantom Stock Units · Derivative | 195.812 | $0.00 Strike: $121.29 | $0.00 |
DisclosureSEC source: 0000911916-18-000013 · edgar.xml · derivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,364.114 Underlying: Common Stock · 195.812 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 13.973 phantom stock units accrued on October 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 18:28 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 226.73 | $0.00 Strike: $121.29 | $0.00 |
DisclosureSEC source: 0000911916-18-000012 · edgar.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,984.026 Underlying: Common Stock · 226.73 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 17.071 phantom stock units accrued on October 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 18:26 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 195.812 | $0.00 Strike: $121.29 | $0.00 |
DisclosureSEC source: 0000911916-18-000011 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,794.979 Underlying: Common Stock · 195.812 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 14.813 phantom stock units accrued on October 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 22:16 UTC |
Hanson Bryan CDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 25,875 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000256 · edgar.xml · derivative · entry 5 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,875 Underlying: Common Stock · 25,875 shares Expires not disclosed F3 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") and each restricted stock unit represents a contingent right to receive one share of Company common stock. F5 · derivative.exercise_date: Vests annually over three years in increments of 33.3% each year, commencing on December 19, 2018. F5 · derivative.expiration_date: Vests annually over three years in increments of 33.3% each year, commencing on December 19, 2018. Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 22:16 UTC |
Hanson Bryan CDirector · President and CEO
|
GrantPerformance Restricted Stock Units · Derivative | 38,280 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000256 · edgar.xml · derivative · entry 4 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,280 Underlying: Common Stock · 38,280 shares Expires not disclosed F3 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") and each restricted stock unit represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: The PRSUs will be earned if and to the extent certain stock price performance goals are achieved by December 19, 2021. Earned PRSUs, if any, will vest on the later of December 19, 2021 or the date the Company's compensation committee determines the number of PRSUs earned. F4 · derivative.expiration_date: The PRSUs will be earned if and to the extent certain stock price performance goals are achieved by December 19, 2021. Earned PRSUs, if any, will vest on the later of December 19, 2021 or the date the Company's compensation committee determines the number of PRSUs earned. Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 22:16 UTC |
Hanson Bryan CDirector · President and CEO
|
GrantPerformance Restricted Stock Units · Derivative | 49,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000256 · edgar.xml · derivative · entry 3 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,425 Underlying: Common Stock · 49,425 shares Expires not disclosed F3 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") and each restricted stock unit represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: The PRSUs will be earned if and to the extent certain stock price performance goals are achieved by December 19, 2021. Earned PRSUs, if any, will vest on the later of December 19, 2021 or the date the Company's compensation committee determines the number of PRSUs earned. F2 · derivative.expiration_date: This award will be forfeited in full if the reporting person fails to acquire in open-market purchases $3,000,000 of Zimmer Biomet Holdings, Inc. (the "Company") common stock within 90 business days of December 19, 2017. F4 · derivative.expiration_date: The PRSUs will be earned if and to the extent certain stock price performance goals are achieved by December 19, 2021. Earned PRSUs, if any, will vest on the later of December 19, 2021 or the date the Company's compensation committee determines the number of PRSUs earned. Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 22:16 UTC |
Hanson Bryan CDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 97,800 | $0.00 Strike: $121.26 | $0.00 |
DisclosureSEC source: 0000911916-17-000256 · edgar.xml · derivative · entry 2 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,800 Underlying: Common Stock · 97,800 shares Expires 2027-12-19 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on December 19, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.